For research use only. Not for human consumption. Affiliate links may earn commissions. Not medical advice.
Back to Catalog
Tirzepatide
120h half-life
MW: 4,813.45
Tyr-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-Aib-Leu-Asp-Lys-Ile-Ala-Gln-Lys(C20 fatty diacid via γGlu-2xOEG linker)-Ala-Phe-Val-Gln-Trp-Leu-Ile-Ala-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2
≥98%
Tirzepatide is a first-in-class 39-amino acid dual GIP/GLP-1 receptor agonist featuring a C20 fatty diacid modification that enables extended half-life, studied extensively for glycemic control and metabolic research applications.
Compare suppliers below for purity, pricing, and availability from vetted research vendors.
Common Research Uses
Incretin receptor research
glycemic control studies
weight management research
metabolic syndrome investigation
insulin sensitivity studies
GIP/GLP-1 dual agonism research
appetite regulation studies
Compare Suppliers
No variants or suppliers have been added yet.
COA / Third-Party Testing
Vetted suppliers provide third-party Certificates of Analysis (COAs). Always verify COAs independently on the supplier's website before purchasing.
Why Compare Here?
We aggregate vetted research suppliers for transparency. Always verify COAs independently.
Affiliate Disclosure: Links on this page may be affiliate links. We may earn a commission at no extra cost to you.